Key facts
- Ruma Care’s last known valuation is $25.0M (Mar 2026).
- It has raised $2.5M; the latest was Early Stage VC ($2.0M) in Mar 2026.
- Notable investors include Y Combinator, Flybridge (New York), Rebel Fund, XFactor Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Ruma Care
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruma Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruma Care
Developer of healthcare workflow automation software designed for specialty medication authorization and reimbursement management support. The company's platform integrates with electronic health record systems to extract patient and insurance data, automate prior authorization form completion, manage copay assistance enrollment, organize clinical documentation, track payer requirements and reimbursement timelines, and coordinate communication with payers and support programs, enabling healthcare providers and specialty clinics to manage administrative processes associated with high-cost treatments.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 3
- Website
- rumacare.com/
- Ownership
- Privately Held (backing)
Ruma Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruma Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruma Care in its N-PORT filings yet. We sweep new filings monthly.